Table 2.
Group A (n=8)
| Sex | Age | Site ofTumor | Treatment | Histology | Follow-up (M) |
|---|---|---|---|---|---|
| M | 70 | CBD | LC Conversion: DCP | T1N0M0 | Alive (62) |
| F | 54 | GB | LC Conversion: Extended cholecystectomy | T3N0M0 | Disease free (90) |
| F | 55 | GB | Laparoscopy + peritoneal biopsy | TxNxM1 | Exitus (6) |
| M | 56 | GB | LC Conversion: Extended cholecystectomy | T3N1M0 | Exitus (6) |
| F | 59 | GB | Laparoscopy + peritoneal biopsy | TxNxM1 | Exitus (8) |
| F | 64 | GB | LC Conversion: Extended cholecystectomy | T2N1M0 | Disease free (15) |
| F | 73 | GB | LC Conversion: Extended cholecystectomy, CBD resection, hepaticojejunostomy | T4N1M1 | Exitus (24) |
| F | 73 | GB | Laparoscopy Conversion: Extended cholecystectomy | T4N1M0 | Exitus (10) |